Publisher
Springer Science and Business Media LLC
Reference42 articles.
1. Partin AW, Kattan MW, Subong EN et al (1997) Combination of prostate-specific antigen, clinical stage, and Gleason score to predict pathological stage of localized prostate cancer. A multi-institutional update. J Am Med Assoc 277(18):1445–1451
2. Edge SB, Byrd DR, Compton CC et al (eds) (2010) AJCC Cancer staging manual, 7th edn. Springer, New York, NY, pp 457–468
3. Ren S, Wang F, Shen J et al (2013) Long non-coding RNA metastasis associated in lung adenocarcinoma transcript 1 derived miniRNA as a novel plasma-based biomarker for diagnosing prostate cancer. Eur J Cancer S0959-8049(13):00360–00362
4. Kelly WK, Scher HI, Mazumdar M, Vlamis V, Schwartz M, Fossa SD (1993) Prostate-specific antigen as a measure of disease outcome in metastatic hormone-refractory prostate cancer. J Clin Oncol 11(4):607–615
5. Parekh DJ, Ankerst DP, Thompson IM (2007) Prostate-specific antigen levels, prostate-specific antigen kinetics, and prostate cancer prognosis: a tocsin calling for prospective studies. J Natl Cancer Inst 99(7):496–497
Cited by
9 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献